Di Bonito M - Search Results

1

Blood oxygenation level dependent magnetic resonance imaging and diffusion weighted MRI imaging for benign and malignant breast cancer discrimination.

Fusco R, Granata V, Pariante P, Cerciello V, Siani C, Di Bonito M, Valentino M, Sansone M, Botti G, Petrillo A. Fusco R, et al. Among authors: di bonito m. Magn Reson Imaging. 2021 Jan;75:51-59. doi: 10.1016/j.mri.2020.10.008. Epub 2020 Oct 17. Magn Reson Imaging. 2021. PMID: 33080334

2

HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression.

Chiappetta G, Botti G, Monaco M, Pasquinelli R, Pentimalli F, Di Bonito M, D'Aiuto G, Fedele M, Iuliano R, Palmieri EA, Pierantoni GM, Giancotti V, Fusco A. Chiappetta G, et al. Among authors: di bonito m. Clin Cancer Res. 2004 Nov 15;10(22):7637-44. doi: 10.1158/1078-0432.CCR-04-0291. Clin Cancer Res. 2004. PMID: 15569996

3

A 2-month cisplatin-epirubicin-paclitaxel (PET) weekly combination as primary systemic therapy for large operable breast cancer: a phase II study.

Frasci G, D'Aiuto G, Comella P, Thomas R, Botti G, Di Bonito M, D'Aiuto M, Romano G, Rubulotta MR, Comella G. Frasci G, et al. Among authors: di bonito m. Ann Oncol. 2005 Aug;16(8):1268-75. doi: 10.1093/annonc/mdi256. Epub 2005 Jun 3. Ann Oncol. 2005. PMID: 15937055 Free article. Clinical Trial.

4

FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders.

Chiappetta G, Ferraro A, Botti G, Monaco M, Pasquinelli R, Vuttariello E, Arnaldi L, Di Bonito M, D'Aiuto G, Pierantoni GM, Fusco A. Chiappetta G, et al. Among authors: di bonito m. BMC Cancer. 2007 Jan 25;7:17. doi: 10.1186/1471-2407-7-17. BMC Cancer. 2007. PMID: 17254320 Free PMC article.

5

Outcome analysis of breast cancer patients receiving breast-conserving surgery in Southern Italy.

Frasci G, Crispo A, D'Aiuto G, Barba M, Rinaldo M, De Marco M, Grimaldi M, Capasso I, Botti G, Di Bonito M, Montella M. Frasci G, et al. Among authors: di bonito m. J Chemother. 2008 Apr;20(2):269-77. doi: 10.1179/joc.2008.20.2.269. J Chemother. 2008. PMID: 18467256

6

Preoperative weekly cisplatin-epirubicin-paclitaxel with G-CSF support in triple-negative large operable breast cancer.

Frasci G, Comella P, Rinaldo M, Iodice G, Di Bonito M, D'Aiuto M, Petrillo A, Lastoria S, Siani C, Comella G, D'Aiuto G. Frasci G, et al. Among authors: di bonito m. Ann Oncol. 2009 Jul;20(7):1185-92. doi: 10.1093/annonc/mdn748. Epub 2009 Feb 13. Ann Oncol. 2009. PMID: 19218307 Free article.

7

Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908.

Frasci G, D'Aiuto G, Comella P, D'Aiuto M, Di Bonito M, Ruffolo P, Iodice G, Petrillo A, Lastoria S, Oliviero P, Capasso I, Montella M, Siani C, Santangelo M, Vizioli L, Comella G; Southern Italy Cooperative Oncology Group (SICOG) Italy. Frasci G, et al. Among authors: di bonito m. Ann Oncol. 2010 Apr;21(4):707-716. doi: 10.1093/annonc/mdp356. Epub 2009 Oct 8. Ann Oncol. 2010. PMID: 19815652 Free article. Clinical Trial.

8

Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial.

Nuzzo F, Morabito A, Gravina A, Di Rella F, Landi G, Pacilio C, Labonia V, Rossi E, De Maio E, Piccirillo MC, D'Aiuto G, Thomas R, Rinaldo M, Botti G, Di Bonito M, Di Maio M, Gallo C, Perrone F, de Matteis A. Nuzzo F, et al. Among authors: di rella f, di maio m, di bonito m. BMC Cancer. 2011 Feb 16;11:75. doi: 10.1186/1471-2407-11-75. BMC Cancer. 2011. PMID: 21324184 Free PMC article. Clinical Trial.

9

Aberrant Expression of Cancer Stem Cells Marker Prominin-1 in Low-Grade Tubulolobular Breast Carcinoma: A Correlative Study between qRT-PCR, Flow-Cytometric and Immunohistochemistry Analysis [corrected].

Di Bonito M, Collina F, Cantile M, Camerlingo R, Cerrone M, Marra L, Liguori G, Pirozzi G, Botti G. Di Bonito M, et al. J Breast Cancer. 2012 Mar;15(1):15-23. doi: 10.4048/jbc.2012.15.1.15. Epub 2012 Mar 28. J Breast Cancer. 2012. PMID: 22493624 Free PMC article.

10

Overexpression of Cell Cycle Progression Inhibitor Geminin is Associated with Tumor Stem-Like Phenotype of Triple-Negative Breast Cancer.

Di Bonito M, Cantile M, Collina F, Scognamiglio G, Cerrone M, La Mantia E, Barbato A, Liguori G, Botti G. Di Bonito M, et al. J Breast Cancer. 2012 Jun;15(2):162-71. doi: 10.4048/jbc.2012.15.2.162. Epub 2012 Jun 28. J Breast Cancer. 2012. PMID: 22807933 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters